Myelodysplastic-Myeloproliferative Diseases

Known as: Myeloproliferative/Myelodysplastic Disorders, Myelodysplastic/Myeloproliferative Disorders, Myelodysplastic/myeloproliferative diseases 
Clonal myeloid disorders that possess both dysplastic and proliferative features but are not properly classified as either MYELODYSPLASTIC SYNDROMES… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2017
010203019952017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Atypical chronic myeloid leukemia (aCML) is a rare subtype of myelodysplastic/myeloproliferative neoplasm (MDS/MPN) largely… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Polycomb group (PcG) proteins are essential regulators of hematopoietic stem cells. Recent extensive mutation analyses of the… (More)
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
In a previous study, we identified somatic mutations of SF3B1, a gene encoding a core component of RNA splicing machinery, in… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2011
2011
The NR4A subfamily of nuclear receptors (NR4A1, NR4A2, and NR4A3) function as transcription factors that transduce diverse… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
TET2 is a close relative of TET1, an enzyme that converts 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) in DNA. The… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Chromosomal abnormalities are frequent in myeloid malignancies, but in most cases of myelodysplasia (MDS) and myeloproliferative… (More)
  • table 1
  • figure 1
  • figure 2
  • table 3
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
lated in ALL are calcitonin, ER, p15, p16, HIC-1, p73, E-cadherin, promoter-associated CpG islands, Wnt and Src among others. In… (More)
  • table 1
  • table 2
Is this relevant?
2008
2008
Allogeneic hematopoietic cell transplantation (HCT) is the only curative strategy for patients with myelodysplastic syndrome (MDS… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
JAK2 V617F mutation recently was identified as a pathogenic factor in typical chronic myeloproliferative diseases (CMPD). Some… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
A mutation in the JH2 pseudokinase domain of the Janus kinase 2 gene (JAK2 V617F) has been described in chronic… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 4
Is this relevant?